Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Newron Pharmaceuticals
Biotech
Cerevel swaps CEO—Chutes & Ladders
Cerevel CEO to step down after four-year run. Day One revamps C-suite. Former Iovance CEO and VC partner jumps to Lassen.
Gabrielle Masson
,
Max Bayer
May 5, 2023 9:30am
Newron's schizophrenia data boost chances of historic approval
Feb 16, 2023 8:30am
Newron ditches sarizotan program after pivotal trial flop
May 4, 2020 7:50am
Newron delays pivotal schizophrenia trials amid safety fears
May 28, 2019 7:22am
Newron hopes to partner schizophrenia drug this year
Jan 26, 2017 7:34am
Newron raises CHF26M to wrap up schizophrenia, CNS studies
Oct 7, 2016 5:00am